Publications by authors named "Daniel N Marco"

Endotheliopathy has been increasingly recognized as a key feature of critical illness. Different diseases and syndromes manifest endothelial dysfunction in their severe forms. Septic syndrome, SARS-CoV-2 disease spectrum, and cell therapy-associated toxicities represent paradigmatic examples of endotheliopathy, in intensive care units.

View Article and Find Full Text PDF

Background: Time to positivity (TTP) and differential TTP (DTP) emerge as diagnostic and prognostic tools for bloodstream infections (BSI) though specific cut-off values need to be determined for each pathogen. Pseudomonas aeruginosa BSI (PAE-BSI) is of critical concern, particularly in immunocompromised patients, due to high mortality rates. Catheter-related infections are a common cause, necessitating rapid and accurate diagnostic tools for effective management (source-control).

View Article and Find Full Text PDF

Background: Arterial catheterisation is a common procedure in intensive care units (ICUs), typically performed using the palpation technique. Ultrasound (US)-guided catheterisation remains underutilised, particularly when performed by nonphysician operators.

Objective: The objective of this study was to assess the effectiveness of US-guided arterial catheterisation performed by nurses in critically ill patients.

View Article and Find Full Text PDF
Article Synopsis
  • - Tacrolimus is crucial for preventing acute graft-versus-host disease (GVHD) in patients undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT), and genetic factors can influence how patients metabolize this drug.
  • - In a study of 62 Caucasian alloHSCT recipients, it was found that the majority (79%) were poor metabolizers, and those with a faster metabolic phenotype had lower Tac concentrations and a higher incidence of acute GVHD.
  • - The findings suggest that genetic testing could help doctors determine the right Tac dose for patients, potentially leading to better outcomes by reaching therapeutic levels faster and reducing GVHD risk.
View Article and Find Full Text PDF

Objectives: (group A [GAS]) is a prevalent cause of community-acquired bacterial infections, with invasive GAS (iGAS) infections presenting severe morbimortality. Clindamycin is generally used based on its antitoxin effect. This study investigates changes in iGAS incidence, clinical presentation, outcomes, and clindamycin resistance in an adult cohort.

View Article and Find Full Text PDF

Introduction: Bone marrow necrosis is a rare entity that can develop in context of a sickle cell disease vaso-occlusive crisis. Its physiopathology is related to an endothelial dysfunction taking place in bone marrow microvasculature.

Case Presentation: A 30-year-old patient with history of compound heterozygous sickle cell disease was admitted following SARS-CoV-2 infection with fever and diarrhea.

View Article and Find Full Text PDF

Objectives: To validate risk factors for mortality in patients treated for COVID-19 in a hospital emergency department during the sixth wave of the pandemic.

Material And Methods: Prospective observational noninterventional study. We included patients over the age of 18 years with a confirmed diagnosis of COVID-19 between December 1, 2021, and February 28, 2022.

View Article and Find Full Text PDF

Tacrolimus (Tac) is a pivotal immunosuppressant agent used to prevent graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (alloHSCT). Tac is characterized by a narrow therapeutic window and a high inter-patient and intra-patient pharmacokinetic variability (IPV). Although high IPV of Tac concentrations has been associated with adverse post-transplant outcomes following solid organ transplantation, the effects of Tac IPV on alloHSCT recipients have not been determined.

View Article and Find Full Text PDF

Objectives: To validate a previously described hospital emergency department risk model to predict mortality in patients with COVID-19.

Material And Methods: Prospective observational noninterventional study. Patients aged over 18 years diagnosed with COVID-19 were included between December 1, 2020, and February 28, 2021.

View Article and Find Full Text PDF